US Critical Metals Corp
USCM
Mydecine Innovations Group Inc
MYCO
Three Valley Copper Corp
TVC.H
Tuga Innovations Inc
TUGA
Windfall Geotek Inc
WIN
CA Stock MarketDetailed Quotes
SZLS StageZero Life Sciences Ltd
- 0.040
- 0.0000.00%
15min DelayMarket Closed Apr 11 09:30 ET
4.94MMarket Cap-245P/E (TTM)
0.000High0.000Low0Volume0.000Open0.040Pre Close0.00Turnover0.05552wk High0.00%Turnover Ratio123.53MShares0.04052wk Low-0.163EPS TTM3.82MFloat Cap108.000Historical HighLossP/E (Static)95.52MShs Float0.035Historical Low-0.149EPS LYR0.00%Amplitude--Dividend TTM-0.36P/B1Lot Size--Div YieldTTM
StageZero Life Sciences Ltd Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -991.86%-62.92K | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 60.59%-3.53M | 77.06%-655.15K | 97.22%-71.07K | 77.21%-558.28K | -104.82%-2.24M |
| Net income from continuing operations | -61.74%-649.46K | 78.68%-386.35K | -1,722.52%-821.88K | 68.67%-401.54K | -206.84%-1.81M | -52.53%-11.42M | -313.78%-9.5M | 97.97%-45.1K | -129.60%-1.28M | 91.91%-590.5K |
| Operating gains losses | 43.83%-147.48K | -92.19%29.41K | 80.57%-188.09K | -2,703.17%-262.55K | 128.57%376.37K | 19.03%-2.24M | 109.22%58.44K | 3.64%-967.84K | 99.86%-9.37K | -123.76%-1.32M |
| Depreciation and amortization | -26.46%43.81K | -69.32%18.28K | -77.52%38.1K | -27.41%59.58K | -36.04%59.58K | -14.10%437.45K | -31.46%125.76K | -20.57%169.44K | 54.91%82.08K | -14.50%93.14K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | --7.36M | ---- | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | --0 | --0 | 75,550.00%9.08K | ---3.67K | --8.18K | -97.14%31.97K | --31.96K | 100.04%12 | --0 | --0 |
| Remuneration paid in stock | -81.92%11.78K | -81.67%11.94K | --261.09K | 139.37%65.16K | -60.63%65.16K | -38.99%238.51K | 134.91%238.51K | --0 | -1,510.23%-165.51K | 170.57%165.51K |
| Other non cashItems | -60.53%69.84K | -82.23%23.58K | 141.53%70.34K | 126.22%176.95K | 118.20%132.7K | -520.52%-1.66M | 71.65%-117.37K | -209.00%-169.37K | -784.84%-674.84K | -1,457.55%-729.18K |
| Change In working capital | 63.11%608.59K | -77.80%210.2K | -27.88%679.17K | -74.98%373.12K | 605.10%946.67K | 905.95%3.71M | 463.44%1.14M | 184.09%941.78K | 2,465.65%1.49M | 112.76%134.26K |
| -Change in receivables | -292.99%-42.56K | 81.40%-7.67K | -130.49%-6.24K | -50.35%22.05K | -309.51%-41.21K | 121.57%95.65K | -83.02%11.11K | 268.89%20.47K | 147.07%44.42K | -76.65%19.67K |
| -Change in inventory | --0 | --0 | 1,725.61%60.37K | --0 | -80.41%12.68K | 682.05%313.18K | -54.32%142.77K | 101.75%3.31K | 200.61%102.4K | 185.64%64.71K |
| -Change in prepaid assets | 113.57%16.06K | 86.08%30.65K | -12.13%59.9K | -11.14%-118.34K | -21.09%16.47K | 205.87%26.09K | 7.98%43.53K | -9.60%68.17K | 25.36%-106.48K | 812.59%20.87K |
| -Change in payables and accrued expense | 17.95%686.14K | -81.35%167.58K | -52.49%450.43K | -60.81%581.73K | 8,782.63%898.48K | 960.22%3.4M | 497.47%957.76K | 229.99%948.08K | 256.25%1.48M | 101.18%10.12K |
| -Change in other working capital | 54.55%-51.06K | -67.41%19.64K | 216.76%114.71K | -234.38%-112.33K | 218.74%60.25K | -326.82%-126.41K | -153.17%-13.47K | -157.83%-98.25K | -70.14%-33.59K | 109.22%18.9K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -991.86%-62.92K | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 60.59%-3.53M | 77.06%-655.15K | 97.22%-71.07K | 77.21%-558.28K | -104.82%-2.24M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | ||||||
| Net PPE purchase and sale | ---- | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 274.50%78.11K | -70.44%72.09K | -177.34%-87.93K | -47.45%20.86K | -78.40%243.85K | -55.34%1.83M | -77.63%650.6K | 215.83%113.7K | -88.68%39.69K | 19.84%1.13M |
| Net issuance payments of debt | 126.39%78.11K | -70.44%72.09K | -202.62%-116.67K | -845.62%-295.95K | 354.85%243.85K | 174.71%290.18K | 442.17%332.47K | 215.83%113.7K | 150.62%39.69K | 16.55%-95.68K |
| Net common stock issuance | --0 | ---- | --18.52K | --279.76K | ---- | -50.36%1.54M | -93.37%206K | --0 | --0 | --1.34M |
| Proceeds from stock option exercised by employees | --0 | ---- | --10.22K | --37.04K | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---112.12K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 274.50%78.11K | -70.44%72.09K | -177.34%-87.93K | -47.45%20.86K | -78.40%243.85K | -55.34%1.83M | -77.63%650.6K | 215.83%113.7K | -88.68%39.69K | 19.84%1.13M |
| Net cash flow | ||||||||||
| Beginning cash position | -84.75%5.54K | 68.22%26.38K | 784.94%64.21K | -94.04%36.3K | -99.09%15.68K | -73.86%1.72M | -97.91%33.25K | -100.22%-9.37K | -90.55%609.21K | -73.86%1.72M |
| Current changes in cash | -45.59%15.19K | -201.15%-20.85K | -194.11%-40.11K | 105.38%27.91K | 101.85%20.61K | 65.19%-1.7M | -103.43%-4.56K | 101.61%42.63K | 76.42%-518.59K | -625.37%-1.12M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---13.01K | ---- | ---- | ---- | ---- |
| End cash Position | -67.73%20.72K | -84.75%5.54K | -27.55%24.09K | -29.15%64.21K | -94.04%36.3K | -99.09%15.68K | -99.09%15.68K | -97.91%33.25K | -97.86%90.63K | -90.55%609.21K |
| Free cash from | -991.86%-62.92K | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 61.24%-3.53M | 77.10%-655.15K | 97.22%-71.07K | 78.47%-558.28K | -104.82%-2.24M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.